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Palo Alto, California 94303 The nuclear factor of activated T cells (NF-AT) is an
immediate-early activation factor that plays a necessary
early role in T cell activation and commitment processes
through its control of interleukin-2 (IL-2) gene activationSummary
(Crabtree, 1989). NF-AT activity has been defined as a
complex family of transcriptional regulators composedClinical deterioration in human immunodeficiency vi-
of a monomeric NF-AT(Rel) component cross-coupledrus type 1 (HIV-1) infection is associated with in-
to a basic-leucine zipper±containing dimer. The NF-ATcreased levels of viral replication and burden in the
Rel components cloned to date are NF-ATp (McCaffreyperipheral bloodand lymphoid organs. T cell activation
et al., 1993), NF-ATc (Northrop et al., 1994), NF-AT3and ensuing cellular gene activation can be critical
(Hoey et al., 1995), and NF-ATx (Masuda et al., 1995).for HIV-1 replication. The hypothesis that the nuclear
The basic-leucine zipper components are thought to befactor of activated T cells (NF-AT) may influence HIV-1
Jun/Fos as activator protein 1 (AP-1) (McCaffrey et al.,replication is therefore compelling given the tight cor-
1993). NF-AT binding activity has been defined as eitherrelation of HIV-1 transcriptional induction to T cell acti-
an NF-AT Rel component binding alone (whether as avation. We report that certain NF-AT(Rel) family mem-
monomer NF-AT(Rel) or as a dimer is not entirely clear)bers productively bind the kB regulatory elements,
or as an NF-AT Rel component in a complex with AP-1synergize with NF-kB and Tat in transcriptional activa-
(Jain et al., 1993; Nolan, 1994; Jain et al., 1995).tion of HIV-1, and enhance HIV-1 replication in T cells.
Speculation that NF-AT may be involved inHIV-1 regu-These results link regulatory factors critical to T cell
lation has led previous investigators to study potentialcommitment directly to HIV-1 replication.
roles for NF-AT in HIV-1 gene expression (Shaw et al.,
1988; Greene, 1990; Lu et al., 1990; Tong et al., 1990).
Despite intense efforts, no causal link has previously
Introduction been established between NF-AT and the activation of
HIV-1 gene expression. The first studies on potential
It has been reported that efficient replication of human NF-AT involvement in HIV-1 began with the recognition
immunodeficiency virus type 1 (HIV-1) can be observed of IL-2 promoter homologies in the HIV-1 LTR, including
at all stages of HIV-1 infection, irrespective of patient the presence of putative NF-AT binding sites in thenega-
status as either asymptomatic or symptomatic (Bagnar- tive regulatory element (NRE). Footprinting studies of the
elli et al., 1992; Michael et al., 1992; Embretson et al.,
DNA region immediately upstream of the kB enhancer
1993; Pantaleo et al., 1993; Piatak et al., 1993; Paul,
motifs indicated the presence of NF-AT binding sites
1995). However, detailed observations indicate that
(Shaw et al., 1988). Analysis of the functions of theseHIV-1 RNA expression and HIV-1 RNA/DNA ratios dra-
upstream NF-AT sites concluded that no activity depen-matically increase during disease progression (Bagnar-
dent on NF-AT could be correlated with the presenceelli et al., 1992; Michael et al., 1992; Piatak et al., 1993).
of these motifs (Markovitz et al., 1992). These and otherThis suggests that the level of HIV-1 RNA expression in
studies resulted in the conclusion that NF-AT was notT cells, together with viral transcriptional activity, corre-
involved in HIV-1 activation through this region (Lu etlates with and influences the progression of HIV-1
al., 1990; Gruters et al., 1991; Lu et al., 1991; Markovitzdisease.
et al., 1992), because deletion and site-directed muta-HIV-1 gene expression is controlled by an interplay
tion of the NF-AT binding sites at nucleotides 2255 toof viral and host regulatory proteins such as Tat, Rev,
2217 in the HIV-1 LTR had no measurable influence onNef, and NF-kB (Cullen, 1991; Haseltine, 1991).The inter-
T cell activation±dependent transcriptional activity (Luaction between these viral and cellular proteins acting
et al., 1990; Markovitz et al., 1992). Despite this negativethrough the HIV-1 long terminal repeat (LTR) is thought
functional data, the hypothesis that NF-AT plays a roleto regulate virus replication, including having effects on
in HIV-1 gene regulation in activated T cells remainsthe pathogenesis and progression of acquired immuno-
attractive, given the role of NF-AT in T cell activation anddeficiency syndrome (AIDS). Among the transcriptional
the tight correlation of HIV-1 transcriptional induction toelements driving HIV-1 expression and regulation, the
kB enhancer regulatory elements at nucleotides 2104 T cell activation.
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Figure 1. NF-AT Enhances Promoter Activity
of HIV-1 LTR through the kB Regulatory
Element
(A) Construction of HIV-1 LTR reporter plas-
mids. The wild- type and 59 deletion mutants
of HIV-1 LTR were linked to the structural
sequence of the firefly luciferase gene. The
NF-ATc cDNA coding region was cloned into
the retroviral expression plasmid pBabeS.
The indicated amounts of pBabeS NF-ATc
and pBabeS b-galactosidase as the internal
control plasmid were transfected into 293
cells with (B) wild-type, (C) mutant I, and (D)
mutant II HIV-1 LTR reporter plasmids, re-
spectively. The experiments were repeated
three times and the results plotted with error
bars; values shown are the average 6 SD.
Reporter plasmid transfected alone is shown
in each graph, is assigned a value of 1, and
is then used to calculate the fold activation.
Transfection efficiencies were normalized to
cotransfected lacZ plasmid driven by the Mo-
loney LTR, known to contain no kB regulatory
elements.
T cell activation is critical for the human immune sys- 1C shows that deletion of the NRE did not decrease
NF-AT activation of the HIV-1 LTR, suggesting that thetem to mount an effective response to pathogenic inva-
sion. Paradoxically, it is T cell activation itself that con- activation we observed after NF-ATc transfections oc-
curs through other sites. When the region between nu-tributes to virus replication and the progressive immune
dysfunction associated with HIV-1 infection, inducing cleotides 2145 and 282 in HIV-1 LTR is deleted, the
transcriptional activity of NF-ATc is markedly reducedevents within cells that enhance HIV-1 transcription
(Greene et al., 1986; Zagury et al., 1986). To understand (Figure 1D). It is noteworthy that the kB regulatory ele-
ments are located here (Nabel and Baltimore, 1987; Sie-more fully the T cell aspects of AIDS pathology, we
reexamined the role(s) of NF-AT in the connections be- kevitz et al., 1987; Tong et al., 1987; Markovitz et al.,
1990).tween events that link T cell commitment processes,
intracellular signaling, and aspects of the HIV-1 life cy- To rule out indirect mechanisms by which NF-AT acti-
vates NF-kB to activate the HIV-1 enhancer, we testedcle. We demonstrate evidence for a fundamental role
for NF-AT in HIV-1 replication processes in T cells. a reporter construct with three tandem repeats of the
kB element of the mouse immunoglobulink chain. (Fujita
et al., 1992). This construct, p55-IgkLuc, was signifi-Results
cantly activated by NF-kB but not by NF-ATc (Table 1);
thus, NF-ATc does not indirectly act on kB elementsInduction of Transcriptional Activity by NF-ATc
Maps to the HIV-1 Enhancer through NF-kB activation. This experiment also demon-
strates that NF-ATc does not have activity through allTo examine whether NF-AT can enhance the promoter
activity of the HIV-1 LTR, we performed cotransfections types of NF-kB motifs. Although NF-ATc contains a Rel
using cloned NF-ATc (Northrop et al., 1994) and HIV-1 domain, as determined both by evolutionary compari-
LTR reporter plasmids (Figure 1). NF-ATc enhanced the sons (Nolan, 1994) and by crystallography (Wolfe et al.,
activity of the HIV-1 LTR more than 10-fold over that of 1997), it is incapable as a monomer of activating through
cells transfected with reporter plasmid alone (basal) in a trimeric Ig-kB site driving a minimal promoter. Thus,
a dose-dependent manner (Figure 1B). However, when NF-AT(Rel) binding likely follows a more complex set of
background luminescence measured from nontrans-
fected cells was subtracted from the basal signal, stimu-
lation of transcription was greater than 45-fold and, in Table 1. NF-AT Does Not Directly or Indirectly Activate
addition, thedose dependency of the NF-kB p65 subunit Transcription through Classic Igk NF-kB-Binding Sites
was the same as that for NF-ATc (data not shown). Fold Activation in Luciferase Activity
Thus, under these standard conditions, NF-ATc and p65
NF-kB NF-ATtransactivate to equivalent levels.
Using truncated HIV-1 LTRs, we began mapping the 0 ng 1.0 6 0 1.0 6 0
50 ng 7.1 6 2.0 1.0 6 0.1region targeted for transcriptional activation by NF-ATc
100 ng 48.6 6 1.1 1.3 6 0.1(Figure 1A). Previous footprinting experiments have sug-
200 ng 398.5 6 36.0 2.1 6 0.1gested that NF-AT holoprotein can bind sites from 2255
The indicated amounts of NF-kB p50/p65 and NF-AT wereto 2217 in the NRE of the HIV-1 LTR (Shaw et al., 1988),
transfected into 293 cells with p55-IgkLuc reporter plasmid. Otherbut it has been demonstrated by several groups that
conditions are the same as those described in the legend to Fig-these sites do not physiologically influence HIV-1 gene
ure 1.
activation (Lu et al., 1990; Markovitz et al., 1992). Figure
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Figure 2. NF-ATc Binds the kB Regulatory Element in the HIV-1 LTR
(A) DNase I footprinting of NF-ATc. The probe containing the nucleotides 2159 to 269 of the HIV-1 LTR was end-labeled on either the coding
or the noncoding strand and partially digested with DNase I in the absence of (lanes F) or in the presence of (lanes B) purified NF-ATc (60
ng). Nucleotide sequence markers prepared from the same fragment using the A1G reaction of Maxam-Gilbert were also electrophoresed
(lanes A1G).
(B) The inducible complexes are eliminated by NF-AT± specific competitors (Comp.). EMSA was performed using the kB regulatory element
(nucleotides 2108 to 278 in HIV-1 LTR) with crude nuclear extracts from Jurkat cells with or without stimulation with 20 ng/ml PMA and 2
mg/ml PHA for 3 hr. Nuclear extracts were preincubated with the indicated oligonucleotide competitors before the addition of radiolabeled
probe. NF-AT WT (mouse IL-2), TCGAGCCCAAAGAGGAAAATTTGTTTCATG; NF-AT mutant, TCGAGCCCAAAGACCTTAATTTGTTTCATACAG;
Igk WT (mouse immunoglobulin k chain), GTCTCGGGACTTTCCATCTC; Igk kB mutant, GTCTCCCACTTTAAGAGAG.
(C) The inducible complexes are recognized by NF-ATc± specific antibody. Nuclear extracts were preincubated with 7A6 NF-ATc±specific
monoclonal antibody before the addition of radiolabeled probe. Other conditions are the same as those described in the legend to Figure 2B.
DNA recognition rules, possibly to accommodate corec- on the noncoding strand (Figure 2A). A similar DNase I
footprint was obtained using NF-ATp (data not shown).ognition of the enhancer region by both NF-ATc and
NF- kB (see below). Some protection of flanking region DNA outside the kB
elements was observed, further suggesting that addi-
tional sequence elements might be required for bindingNF-ATc Binds to the kB Enhancer
and Flanking DNA Regions of NF-ATp/c and activation of the HIV-1 promoter.
We next examined whether nuclear extracts preparedTo confirm that NF-ATc binds to the HIV-1 enhancer
region between nucleotides 2145 and 282 in the LTR, from Jurkat T cells contained an NF-AT±specific activity
that bound to the kB enhancer of HIV-1 by preparingdeoxyribonuclease I (DNase I) footprinting was per-
formed using purified NF-ATc. Clear DNase I protection nuclear extracts using a biochemical protocol that ex-
tracts nuclear-localized NF-AT complexes (Flanagan etby purified NF-ATc was observed to encompass com-
pletely the DNA region from nucleotides 2104 to 274 al., 1991). We observed two induced complexes in phor-
bol myristate acetate (PMA)± and phytohemagglutininon the coding strand and from nucleotides 2104 to 277
Immunity
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Figure 3. NF-AT and NF-kB Activation of
HIV-1 Have Distinct butOverlapping DNA Mo-
tif Requirements
(A) Nucleotide sequence of the kB regulatory
elements in HIV-1 LTR. Shown are wild-type
sequences of the kB regulatory motif, the en-
hancer region mutant at residues critical to
NF-kB, and the region mutant in the spacer
region, shown previously (Perkins et al., 1994)
to prevent binding of AP-2 but to have no
effect on NF-kB binding. The indicated
amounts of NF-kB, p50/p65, and NF-AT were
transfected into 293 cells with kB mutant (B)
and AP-2 mutant (C) HIV-1 LTR reporter plas-
mids, respectively. Other conditions are the
same as those described in the legend to
Figure 1.
(PHA)±stimulated Jurkat nuclear extracts. Electromo- activity that increased in a dose-dependent manner (Fig-
ure 3B). In contrast, when the spacer region between thebility shift assays (EMSA) were performed using cold
kB elements was mutated, the opposite effect occurred:oligonucleotides to NF-AT± or NF-kB±binding sites as
NF-kB showed dose-dependent transcriptional activity,specific competitors. Wild-type NF-AT oligonucleotide
whereas the NF-ATc transcriptional activity was abol-competes for the upper and lower complexes, whereas
ished (Figure 3C). These data show that although NF-wild-type Igk oligonucleotide competes for the upper
ATc can bind to elements containing certain kB-likecomplex alone. NF-AT and NF-kB site oligonucleotides
motifs in their core sequences (McCaffrey et al., 1992;mutant at residues known to prevent binding of their
Nolan, 1994), NF-ATc binding to the kB regulatory ele-respective proteins did not inhibit the binding of any
ments of HIV-1 has subtle requirements that distinguishcomplexes in these gel shifts (Figure 2B). To confirm
its binding from those of the NF-kB class of Rel factors.that these complexes induced by PMA and PHA include
This conclusion is supported by recent crystallographicNF-AT, supershift gel shift assays were performed using
data of the NF-ATc DNA-binding domain (Wolfe et al.,NF-ATc specific antibody (7A6). The upper and lower
1997).complexes were completely supershifted by this anti-
body (Figure 2C). This NF-ATc antibody is mouse mono-
Synergistic Transcriptional Activationclonal antibody prepared against a non-Rel region of
of NF-ATc and NF-kB through the kBNF-ATc. This antibody does not cross-react with NF-kB
Regulatory Elementand does not lead to shifting of naked radiolabeled
NF-ATc and NF-kB recognize overlapping but distinctprobe DNA (data not shown). Thus, the data support
DNA sequences in the kB enhancer elements of the
the hypothesis that nuclear extracts prepared from acti-
HIV-1 LTR. To examine further whether NF-ATc and NF-
vated T cells contain complexes that are composed at
kB can interact transcriptionally at the HIV-1 enhancer,
least in part by NF-ATc. we analyzed HIV-1 transcriptional activity with cotrans-
fected combinations of expression vectors for NF-kB
subunits p50, p65, and NF-ATc. A strong synergisticNF-ATc and NF-kB Recognize Distinct DNA
effect was observed when NF-ATc was cotransfectedSequences within and Proximal to the kB
with NF-kB heterodimer (p50 plus p65) or the NF-kB
Regulatory Elements
(p65) subunit on reporter plasmids driven by either the
NF-ATc enhances transcriptional activity through re- wild-type or mutant I HIV-1 LTR. No synergistic effect
gions called the kB regulatory elements in the HIV-1 was observed between p50 and NF-ATc (Figures 4A and
LTR, but it had no effect on classic NF-kB±binding sites 4B). However, when the kB enhancer was deleted, no
driving a minimal promoter (Figure 1 and Table 1). More- synergistic effect was observed with any of the combi-
over, the protected region of NF-ATc DNase I foot- nations of transfected proteins (Figure 4C). NF-kB has
printing extends outside the NF-kB±binding sites in the been shown to synergize with other proteins at the HIV-1
HIV-1 LTR (Figure 2A). This suggests there are sequence promoter, such as AP-1 components (Stein et al., 1993),
requirements for NF-AT binding that are independent but the synergy of NF-ATc with NF-kB is greater than
of residues comprising the canonical NF-kB sites. To that of AP-1 components with either NF-ATc or NF-kB,
examine this possibility, we performed cotransfections and AP-1 also did not influence the synergistic interac-
using HIV-1 LTRs mutant at the kB motifs (Nabel and tion of NF-ATc and NF-kB (data not shown).
Baltimore, 1987) or the 4 bp spacer region between the
duplicated kB motifs that have been suggested to bind T Cell Signals That Activate NF-ATc Specifically
AP-2 (Perkins et al., 1994) (Figure 3A). When the kB sites Induce HIV-1 Gene Activity in a
were mutated, transfected NF-kB was not transcription- Tat-Stimulated Manner
ally active on the mutated HIV-1 LTR, as expected. On The HIV-1 regulatory protein Tat is a potent transactiva-
tor of HIV-1 gene expression (Arya et al., 1985), therethe other hand, NF-ATc had significant transcriptional
NF-AT Activates HIV-1 Replication in T Cells
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Table 2. NF-AT Participates in Tat-Induced Activation of HIV-1
Promoter Activity
A Fold Activation in Luciferase
Activity
2 Tat 1 Tat (25 ng)
None 1.0 6 0 34.4 6 1.9
NF-AT 2.3 6 0.1 195.7 1 3.250 ng
75 ng 7.2 6 0.1 466.2 6 41.8
100 ng 12.7 6 0.6 623.4 6 19.4
NF-kB 3.3 6 0.3 167.0 6 6.550 ng
75 ng 8.2 6 0.4 237.5 6 7.3
100 ng 14.8 6 1.1 448.8 6 2.3
NF-AT 1 NF-kB 12.0 6 0.6 341.6 6 3.850 ng
75 ng 45.8 6 2.4 1098.9 6 88.2
100 ng 99.1 6 5.0 1659.3 6 23.7
B Fold Activation in Luciferase
Activity
Stimulation Jurkat Jurkat 1 Tat
None 1.0 6 0 25.5 6 2.6
CsA 1.0 6 0.2 19.2 6 3.6
PHA 2.0 6 0.1 80.8 6 1.1
PHA 1 CsA 1.2 6 0.1 36.2 6 2.5
TNFa 3.5 6 0.6 81.5 6 0.8
TNFa 1 CsA 3.3 6 0.2 77.3 6 3.7
PHA 1 TNFa 6.8 6 0.8 298.7 6 13.7
PHA 1 TNFa 1 CsA 5.6 6 0.2 180.8 6 12.7
(A) Wild-type HIV-1 LTR luciferase reporter plasmid was transfected
into 293 cells with the indicated amounts of tat, NF-kB (p50/p65),
and NF-AT expression vectors. Other conditions are the same as
those described in the legend to Figure 1.
(B) Wild-type HIV-1 LTR luciferase reporter plasmid was transfected
with or without tat expression vector into Jurkat cells. Cells were
Figure 4. Synergistic Transcriptional Activation of NF-ATc and treated for 3 hr with various agents (PHA 2 mg/ml, TNFa 10 ng/ml,
NF-kB and CsA 500 ng/ml) prior to measurement of luciferase activity.
The HIV-1 LTR reporter plasmid, wild- type (A), mutant I (B), and
mutant II (C) were transfected into 293 cells with the indicated
amounts of p50, p65, and NF-ATc expression vectors. Other condi-
gene activation, cyclosporin A (CsA), an inhibitor oftions are the same as those described in the legend to Figure 1.
Ca21-dependent signaling in T cells, was used as a spe-
cific pharmacologic inhibitor of NF-AT (Flanagan et al.,
1991). Cotransfection of wild-type HIV-1 LTR reporterbeing general agreement that Tat is physiologically criti-
cal for efficient HIV-1 replication (Fisher et al., 1986). To plasmid with Tat expression vector enhanced luciferase
activity about 25-fold. When Jurkat cells expressing Tatexamine whether NF-AT can influence Tat activity in
vivo, we cotransfected combinations of Tat, NF-kB, and were stimulated with either PHA or TNFa, luciferase
activities increased about 80-fold in eachcase. AlthoughNF-ATc expression vectors with wild-type HIV-1 LTR
reporter plasmid. A strong synergistic transcriptional CsA inhibited Tat-expressing, PHA-induced HIV-1 LTR
transcriptional activity, this agent had almost no influ-effect on the HIV-1 promoter was observed when Tat
and NF-ATc were cotransfected. Furthermore, the syn- ence on TNFa-induced Tat-dependent activation. Fur-
thermore, costimulation with PHA and TNFa resulted inergistic effect of Tat, NF-kB, and NF-ATc in combination
is much stronger than the synergistic effects of either synergistic effects on transcriptional activation of HIV-1,
and this activity was also inhibited by CsA (Table 2B).Tat plus NF-kB or the effects of Tat plus NF-ATc (Table
2A). To examine whether cellular NF-AT potentiates We verified the activation status of NF-ATc and NF-
kB under our stimulatory conditions by Western blotgene expression induced by Tat in T cells, we cotrans-
fected a Tat expression vector with wild-type HIV-1 LTR analysis. NF-ATc was induced by PHA but not by TNFa.
In contrast, NF-kB was induced by TNFa but not byreporter plasmid into Jurkat cells. These transfected
cells were stimulated by PHA or tumor necrosis factor PHA; CsA affected NF-ATc phosphorylation status but
did not influence NF-kB activation (Figure 5), correlatinga (TNFa); either condition alone, or the conditions in
combination, are known to increase HIV-1 replication with the data in Table 2B.
(Zagury et al., 1986; Poli et al., 1990). PHA induction
mimics certain activation events by the T cell receptor, NF-ATc Enhances HIV-1 Replication in T Cells
Finally, to examine whether NF-AT influences HIV-1 rep-stimulating T cell activation through Ca21-dependent
signaling pathways, leading to NF-AT activation (Crab- lication, experiments were performed using a replica-
tion-competent HIV-1 isolate. First, using recombinanttree, 1989). In contrast, TNFa is an important activator
of NF-kB (Schutze et al., 1992) and is not known to retroviral vectors, we prepared a cell line that stably
overexpressed NF-ATc (SupT1:NF-ATc-Lyt2) and a con-activate NF-AT or Ca21-dependent signaling in T cells.
To examine the influence of NF-AT in Tat-induced HIV-1 trol cell line (SupT1:control-Lyt2) to isolate the effects
Immunity
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Figure 5. NF-ATc and NF-kB p65 Are Separately Induced by PHA
and TNFa, Respectively, in Jurkat T Cell Lines
Jurkat cells were treated for 3 hr with agents (PHA 2 mg/ml, TNFa
Figure 6. NF-ATc Is a Positive Regulatory Factor for HIV-1 Repli-10 ng/ml, and CsA 500 ng/ml). Nuclear extracts were boiled with
cationSDS-PAGE sample buffer and analyzed by Western blot using an
anti-NF-ATc monoclonal antibody, 7A6 (top), or an anti p65 poly- SupT1:NF-ATc-Lyt2 and SupT1:control-Lyt2 cells were challenged
clonal antibody (bottom). with HIV-1 (NL4±3) at a dose of 400 TCID50 per 5 3 104 cells. p24gag
levels in culture supernatants were assayed from triple wells on the
indicated days after infection. p24 levels were normalized for cellof NF-ATc from contributions by other cellular factors.
number using an XTT assay. Data are presented as the average 6
Both cell lines grew at equal rates over several weeks, SD per 106 cells. Similar results were observed in four independent
suggesting that there is no growth advantage or disad- experiments.
vantage when NF-ATc is overexpressed. Western blot
analysis showed that NF-ATc overexpression leads to replication of wild-type HIV-1. NF-ATp/c bound to the
some NF-ATc nuclear translocation inunstimulated cells HIV-1 kB enhancer motifs (nucleotides -104 to 281), a
(data not shown). HIV-1, strain NL4±3 (Adachi et al., region formerly thought tobind only NF-kB, and its bind-
1986), was infected into the modified SupT1 cells at a ing correlated to positive transcriptional activation of
viral titer of 400 TCID50 (50% tissue culture infective the promoter.Although investigators have indicated that
dose) per 5 3 104 target cells. Each time point was taken NF-AT binds to sites upstream from the kB motifs (Shaw
in triplicate, and the results were normalized for cell et al., 1988), others have noted that these NF-AT sites
number. Over a time course of 14 days we measured have no biological function (Lu et al., 1990; Tong et al.,
HIV-1 replication activity using a p24 enzyme-linked im- 1990; Lu et al., 1991; Markovitz et al., 1992) in T cells in
munosorbent assay (ELISA). Five days after infection, the context of the HIV-1 enhancer/promoter. The data
virus replication was detected at similar levels for presented in this report suggest that previous work fo-
SupT1:NF-ATc-Lyt2 and SupT1:control-Lyt2 cells. Syn- cusing on these upstream sites was insufficient to con-
cytia formation was observed beginning at this time clude a lack of NF-AT involvement in HIV-1 regulation.
point. Seven days after infection there was a significant Consistent with our finding that NF-ATc activates the
increase in viral replication in the NF-ATc overexpress- HIV-1 LTR, other investigations have shown clear indi-
ing cells over that observed in the control cells (Figure cations of calcium-dependent signaling that activate
6). By day 9, a high percentage of cells were observed throughthe HIV-1 kB enhancer regions.Many early stud-
as syncytia in both the NF-ATc± overexpressing cells ies of HIV-1 gene activation used PHA as the activator
and the NF-ATc control cells. At this time point and at of Ca21 signaling pathways. Although activation of HIV-1
days 12 and 14 there was a consistently higher level through PHA/Ca21 pathways has previously been sug-
of virus production as read by p24 levels in the NF- gested to be dependent entirely on NF-kB protein activ-
ATc±overexpressing cells as compared to the control ity, Ca21 signaling is a hallmark of NF-AT activation in
vector cells (Figure 6). The results were similar in four T cells (Crabtree, 1989; Hodge et al., 1995; Lee et al.,
independent experiments. After 14 days, most cells 1995; Masuda et al., 1995; Rooney et al., 1995; Hodge
were dead and the experiment was terminated. To rule et al., 1996; Luo et al., 1996). It is noteworthy, and it
out the possibility that NF-ATc activated NF-kB to in- supports the conclusions of this report, that CsA com-
duce HIV-1 replication, transfection of p55-IgkLuc re- pletely abolished a PHA-induced binding activity to the
porter plasmid into SupT1:control-Lyt2 and SupT1:NF- kB regulatory elements and transcriptional induction of
ATc-Lyt2 cells confirmed that NF-ATc overexpression the HIV-1 LTR when cells were induced with PHA; CsA
does not directly or indirectly activate NF-kB (data not had almost no influence on PMA-induced complexes or
shown). LTR activation (Schmidt et al., 1990). This is consistent
with the fact that CsA can inhibit PHA-mediated NF-AT
Discussion nuclear translocation and transcriptional activity but not
PMA-mediated NF-kB induction. These data are ex-
In this study we have demonstrated that NF-ATc can plained by postulating roles for either NF-AT and NF-
kB in HIV-1 gene regulation, depending on the inducingserve as a positive activator of HIV-1 transcription and
NF-AT Activates HIV-1 Replication in T Cells
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signal received by the T cell. Notably, Franza and col- the spacer region abolished NF-ATc activation, sug-
gesting that NF-ATc requires nucleotides within this re-leagues (1987) reported that a 110 kDa protein could be
gion for activation of the HIV-1 enhancer. Mutation ofrecognized binding to the tandem kB enhancer motifs
the kB elements at the GGG residues at the 59 end offrom the whole-cell extracts of H9, CD41 human T
the motif had no effect on HIV-1 activation after cotrans-lymphoblast line. Although other proteins in that study,
fection of reporter genes and NF-ATc into 293 cells.HIVEN86 and a series of 50 kDa proteins, were later
However, full physiological activation of HIV-1 in T cellsidentified as human c-Rel (Ballard et al., 1990) and the
might require the presence of both NF-kB and NF-ATNF-kB subunit p50 (Kawakami et al., 1988), the 110 kDa
at the HIV-1 LTR. It is noteworthy that infection withprotein has not been identified so far. Since, by SDS±
HIV-2 (which has only a single kB element in its en-polyacrylamide gel electrophoresis (SDS-PAGE), NF-AT
hancer) results in a longer asymptomatic phase in in-homologs (c and p) both have molecular masses of ap-
fected individuals (Markovitz et al., 1990). It will be inter-proximately 120 kDa (McCaffrey et al., 1993; Northrop
esting to correlate the presence of NF-kB and NF-ATet al., 1994), it is possible that the 110 kDa protein is
binding determinants to LTR promoter activation usingNF-AT.
HIV-2 and other HIV-1 subtypes that contain variationPrevious studies have concluded that because HIV-
in the enhancer regions. In addition, this analysis mightCAT (chloramphenicol acetyl transferase) activity was
suggest that variations in promoter activity among dif-dramatically enhanced by Tat in PHA plus PMA±
ferent strains of HIV-1 might correlate to different patho-stimulated Jurkat T cells, this activation is due to contri-
logic outcomes or adaptation to the use of differentbutions by interaction of NF-kB and Tat (Nabel and Balti-
transcription factors present in target cells that HIV-1more, 1987). Since activation of T cells with PHA and
strains infect.PMA is a classic method by which NF-AT is activated,
Finally, it has previously been reported that CsA inhib-and since NF-AT proteins bind at the tandem kB regula-
its HIV-1 replication (Karpas et al., 1992; Thali et al.,tory elements as evidenced from the nuclear extract of
1994). Studies by Franke and colleagues (1994) and ThaliPHA plus PMA±stimulated Jurkat cells (Figures 2B and
and colleagues (1994) concluded that CsA inhibits HIV-12C), NF-AT is as equally positioned and as appropriately
by blocking the interactions between HIV-1 Gag poly-regulated as NF-kB to contribute to Tat-induced HIV-1
protein and cyclophilin A as HIV-1 virions are being as-gene activation in T cells. Indeed, the coordinate binding
sembled to leave the cell, resulting in immature virionof NF-AT and p65-containing NF-kB complexes to one
production. Questions, however, remain as to whetheror the other of the duplicated kB motifs in the HIV-1
this is the only mechanism by which CsA effects theenhancer region might allow synergistic interactions of
HIV-1 life cycle. Since HIV-1 transcription and virion pro-these proteins with Tat bound to TAR, greatly enhancing
duction are inhibited by CsA treatment (Schmidt et al.,subsequent transcriptional activation of HIV-1 gene.
1990; Karpas et al., 1992), at least one inhibitory effectAlthough there have been indications that NF-AT
of CsA acts prior to any potential effect CsA can havemight bind certain NF-kB±like motifs, there have been
on Gag interaction with cyclophilin A. It is reasonableno reports of NF-AT transcriptional activity through such
to conclude that this transcriptional inhibition can beelements (McCaffrey et al., 1992; Jain et al., 1995). NF-
brought about by the action of CsA on NF-AT activationATc had no transcriptional activity, directly or indirectly,
in T cells, given the results in our current report.through triplicate consensus kB elements driving a mini-
We have demonstrated that immediate-early T cellmal promoter (Table 1).The same monomeric kB present
activation proteins, such as NF-ATc and NF-kB, can beas tandem repeats in the HIV-1 enhancer were potently
exploited by HIV-1 to enhance its replication. Since NF-responsive to NF-ATc. This suggests that the kB regula-
AT and NF-kB proteins are distantly related in their Rel
tory elements in the context of HIV-1 LTR sequences
DNA-binding region (Nolan, 1994; Northrop et al., 1994;
likely represent a special class of kB motifs capable of
Luo et al., 1996), and since each can bind to the HIV-1 kB
being bound by either NF-kB or NF-AT classes of Rel
enhancer region after induction by alternative signaling
proteins. Thus, duplicated NF-kB binding sites in the pathway in lymphocytes, these transcription factors
HIV-1 LTR might confer binding of multiple, discrete, would be advantageous for HIV-1 utilization during T cell
proteins from the NF-kB and NF-AT Rel subfamilies of signaling-dependent activation. Therefore, the findings
regulators, giving rise to the potential for synergistic here suggest that closer examination of immediate-early
transactivation. Supporting this possibility are data T cell events, such as NF-AT activation (Hodge et al.,
showing that mutation of either one of the two kB regula- 1995; Lee et al., 1995; Masuda et al., 1995; Rooney et
tory elements (BoÈ hnlein et al., 1988), or of different se- al., 1995; Hodge et al., 1996; Luo et al., 1996), that lead
quences inserted between the duplicated kB binding to induction of HIV-1 gene activation might promote the
sites (Perkins et al., 1994), leads to a dramatic reduction development of T cell±specific therapies that limit the
in the transactivation of the HIV-1 LTR. The differential pathogenic progression of AIDS.
mode of DNA recognition by NF-ATc suggested by crys-
tallographic studies supports our findings that NF-ATc Experimental Procedures
recognizes distinct DNA elements from NF- kB in the
Plasmid ConstructionkB enhancer elements.
NF-ATc, p50, p65 b-galactosidase, and Tat expression vectorsMutational analysis of the regions within and sur-
(pBabeS NF-ATc, pBabeS p50, pBabeS p65, pBabeS b-galactosi-
rounding the HIV-1 kB elements support the contention dase, and pBabeMN Tat) were constructed by inserting the coding
that NF-ATc and NF-kB binding and activation require- sequences of the respective cDNAs into retrovirus expression vec-
tors, pBabeS or pBabeMN. pBabeS is derived from pBabePuro,ments overlap but remain distinguishable. Mutation of
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contains changes in the multicloning site, and has been deleted for for Lyt2 expression. Subsequent analysis showed that cells carrying
the NF-ATc retroviral vector were strongly positive for expressionthe SV40-neo region of pBabePuro (Morgenstern and Land, 1990).
The 59 LTR and c-packaging signals of pBabe MN were driving from of NF-ATc.
the MFG vector (Dranoff et al., 1993). pBabeMN IRES-Lyt2a9 was
derived by ligating IRES-Lyt2a9 (a kind gift from P. Achacoso, Stan- HIV Infection and p24 Assay
ford University) downstream of the multicloning site of pBabeMN. SupT1:control-Lyt2 or SupT1:NF-ATc-Lyt2 cells were plated in tripli-
Lyt2a9 is the splice variant of murine CD8 that lacks a cytoplasmic cates in 48-well plates (5 3 104/well) in RPMI 1640 medium con-
tail. The IRES (internal ribosome entry site) functionality allows multi- taining 10% FCS. HIV-1 infection was performed by incubating cells
ple proteins to be driven off of a single promoter. In this manner, with NL4±3 (400 TCID50/well in 0.5 ml of culture medium) at 378C for
NF-ATc expression from the retroviral promoter can be directly cor- 4 hr. Medium was replaced with 1 ml of fresh medium. Supernatant
related to Lyt2a9 expression. was collected at the indicated days after infection and replaced
with fresh medium. An ELISA assay kit (Abbott Laboratories) was
used to determine the p24gag levels as a measure of HIV-1 replication.Luciferase Assays
293 cells were cultured in DMEM containing 10% fetal calf serum
(FCS). 293 cells were seeded at 5 3 104 cells per well in 24-well XTT Assay
plate. Twenty-four hours later, cells were transfected with 10 ng of XTT assay was performed as described previously (Jellinger et al.,
the reporter plasmid, the indicated amounts of expression vectors, 1997). Fifty microliters of a solution containing 1.5 mM 2,3-bis[2-
and 50 ng of pBabeS b-galactosidase by the calcium phosphate methoxy-4-nitro-5-sulfophenyl]-5-[(phenylamino)carbonyl]-2H-tet-
coprecipitation technique. The total amount of DNA was held con- razolium hydroxide (XTT) (Polysciences, Warrington, Pennsylvania)
stant by using pUC 18 carrier DNA. Cells were harvested 48 hr after and 125 mM phenazine methosulfate (Sigma, St. Louis, Missouri)
transfection and measured for luciferase activity as described (de was added to 150 ml of cell samples in flat-bottomed 96-well plates.
Wet et al., 1987). b-Galactosidase activity was assayed by standard The plate was sealed with adhesive plate sealer and the contents
methods. Jurkat cells were cultured in RPMI 1640 containing 10% of the plate were mixed. After incubation for 4 hr at 378C, the plate
FCS. Cells (5 3 106) were transfected with 5 mg of reporter plasmid was placed in a V-Max spectrophotomer (Molecular Devices, Menlo
and 2 mg of tat expression vector or pUC 18 carrier DNA by the Park, California). The optical densities of each well were read at a
diethylaminoethyl-dextran method. Thirty-six hours after transfec- test wavelength of 450 nm and reference wavelength of 650 nm.
tion, cells were treated as indicated and cellextracts were measured The standard linearity of the assay extended from 250 to 10,000
for luciferase activity. cells. Results from XTT assays were used to normalize p24 assays
at different time points of the assay.
DNase I Footprinting
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